Additionally, both ACE inhibitors or angiotensin receptor blockers effectively suppress NSCLC cell proliferation as well as metastases to prevent further tumor formation (Maluccio et al., 2001; Attoub et al., 2008). The gene discussed is ACE; the disease is neoplasm.